Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes

[1]  K. Makimura,et al.  Candidemia in Children Caused by Uncommon Species of Candida , 2018 .

[2]  Jang-Jih Lu,et al.  Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia , 2017, Scientific Reports.

[3]  J. Pemán,et al.  Risk factors, clinical presentation and prognosis of mixed candidaemia: a population‐based surveillance in Spain , 2016, Mycoses.

[4]  P. Escribano,et al.  Risk factors for late recurrent candidaemia. A retrospective matched case-control study. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  J. Sobel,et al.  Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  J. Sobel,et al.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  J. Pemán,et al.  Breakthrough candidaemia in the era of broad-spectrum antifungal therapies. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[8]  R. Ben-Ami,et al.  Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[9]  Shao-Hung Wang,et al.  Clinical and molecular characteristics of bloodstream infections caused by Candida albicans in children from 2003 to 2011. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[10]  D. Kontoyiannis,et al.  Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA , 2015, Emerging infectious diseases.

[11]  A. Chakrabarti,et al.  Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[12]  D. Skaare,et al.  Twenty-two years of candidaemia surveillance: results from a Norwegian national study. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[13]  N. Singhal,et al.  MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis , 2015, Front. Microbiol..

[14]  M. Antonelli,et al.  A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality , 2015, Intensive Care Medicine.

[15]  P. Muñoz,et al.  Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: results from a population-based surveillance in Spain. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[16]  M. Ghezzi,et al.  Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[17]  F. Thoemmes,et al.  Propensity Score Analysis , 2015 .

[18]  P. Hamal,et al.  Invasive Candida infections in surgical patients in intensive care units: a prospective, multicentre survey initiated by the European Confederation of Medical Mycology (ECMM) (2006-2008). , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[19]  M. Dornelas-Ribeiro,et al.  Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. , 2015, The Journal of antimicrobial chemotherapy.

[20]  R. Porcher,et al.  Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  P. Clarke,et al.  Neonatal invasive fungal infection in England 2004-2010. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  M. Balaguer,et al.  Per-species Risk Factors and Predictors of Invasive Candida Infections in Patients Admitted to Pediatric Intensive Care Units: Development of ERICAP Scoring Systems , 2014, The Pediatric infectious disease journal.

[23]  J. Schrenzel,et al.  Candida species distribution and antifungal susceptibility testing according to European Committee on Antimicrobial Susceptibility Testing and new vs. old Clinical and Laboratory Standards Institute clinical breakpoints: a 6-year prospective candidaemia survey from the fungal infection network of Sw , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[24]  J. Pemán,et al.  Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU* , 2014, Critical care medicine.

[25]  J. Pemán,et al.  Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  J. Aguado,et al.  Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[27]  T. Perl,et al.  Epidemiology of Candida kefyr in Patients with Hematologic Malignancies , 2014, Journal of Clinical Microbiology.

[28]  F. Queiroz-Telles,et al.  Active Surveillance of Candidemia in Children from Latin America: A Key Requirement for Improving Disease Outcome , 2014, The Pediatric infectious disease journal.

[29]  Chiang-Wen Lee,et al.  Risk Factors and Outcomes for Multidrug-Resistant Gram-Negative Bacteremia in the NICU , 2014, Pediatrics.

[30]  M. Angelopoulou,et al.  A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[31]  N. León-Sicairos,et al.  Species distribution and antifungal susceptibility of bloodstream fungal isolates in paediatric patients in Mexico: a nationwide surveillance study. , 2013, The Journal of antimicrobial chemotherapy.

[32]  E. Roilides,et al.  Invasive candidiasis in pediatric intensive care in Greece: a nationwide study , 2013, Intensive Care Medicine.

[33]  D. Benjamin,et al.  Results From a Prospective, International, Epidemiologic Study of Invasive Candidiasis in Children and Neonates , 2012, The Pediatric infectious disease journal.

[34]  C. Liao,et al.  Association between incidence of candidaemia and consumption of antifungal agents at a medical centre in Taiwan. , 2012, International journal of antimicrobial agents.

[35]  M. Pfaller,et al.  Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012 , 2012, Journal of Clinical Microbiology.

[36]  T. Zaoutis,et al.  Epidemiology, Risk Factors and Outcome of Candida parapsilosis Bloodstream Infection in Children , 2012, The Pediatric infectious disease journal.

[37]  C. Clancy,et al.  Performance of Candida real-time polymerase chain reaction, β-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  J. Guinea,et al.  Epidemiology and Antifungal Susceptibility of Bloodstream Fungal Isolates in Pediatric Patients: a Spanish Multicenter Prospective Survey , 2011, Journal of Clinical Microbiology.

[39]  D. Palazzi,et al.  Candida Non-albicans Versus Candida Albicans Fungemia in the Non-neonatal Pediatric Population , 2011, The Pediatric infectious disease journal.

[40]  M. Bassetti,et al.  Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. , 2009, The Journal of antimicrobial chemotherapy.

[41]  D. Marriott,et al.  Candidaemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[42]  D. Warren,et al.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  S. Suh,et al.  Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[44]  J. Perfect,et al.  Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  D. Marriott,et al.  Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp. , 2008, Critical care medicine.

[46]  Y. Carmeli,et al.  Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[47]  S. Lockhart,et al.  Lodderomyces elongisporus Masquerading as Candida parapsilosis as a Cause of Bloodstream Infections , 2007, Journal of Clinical Microbiology.

[48]  Suhail Ahmad,et al.  Outbreak of Fungemia among Neonates Caused by Candida haemulonii Resistant to Amphotericin B, Itraconazole, and Fluconazole , 2007, Journal of Clinical Microbiology.

[49]  K. Anstrom,et al.  Comparative Evaluation of Etest and Sensititre YeastOne Panels against the Clinical and Laboratory Standards Institute M27-A2 Reference Broth Microdilution Method for Testing Candida Susceptibility to Seven Antifungal Agents , 2007, Journal of Clinical Microbiology.

[50]  Clinical practice guidelines for the treatment of histoplasmosis have been updated by the Infectious Disease Society of America. , 2007 .

[51]  J. Guarro,et al.  Phenotypic and Molecular Characterization of Candida nivariensis sp. nov., a Possible New Opportunistic Fungus , 2005, Journal of Clinical Microbiology.

[52]  A. Rodríguez-Núñez.  Incidence and Mortality of Proven Invasive Candida Infections in Pediatric Intensive Care Patients , 2001, Infection Control & Hospital Epidemiology.

[53]  I. Raad,et al.  Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.